Market Overview
According to fortune business insights, the global radiofrequency ablation devices market size was valued at USD 5.13 billion in 2025. The market is projected to grow from USD 5.59 billion in 2026 to USD 9.63 billion by 2034, exhibiting a CAGR of 7.1% during the forecast period. North America dominated the radiofrequency ablation devices market with a market share of 42.88% in 2025.
The latest research report on the “Radiofrequency Ablation Devices Market, 2026-2034” provides a detailed analysis of these insights.
The analysis shows that top companies are investing more in radiofrequency ablation devices as hospitals and specialists increasingly favor minimally invasive therapies. For example, Johnson & Johnson, Boston Scientific Corporation, Abbott, and Medtronic plc International held the largest market share, driven by increasing investments and strategic initiatives. This trend indicates strong demand for radiofrequency ablation devices worldwide.
Major Players Profiled in the Market Report:
Segments
Strong Electrophysiology Demand to Propel Cardiac Arrhythmia Ablation Segment Growth
Based on application, the market is divided into cardiac arrhythmia ablation, pain management and neuromodulation, oncology, and others. The cardiac arrhythmia ablation segment holds the largest market share and dominates the market owing to the high clinical need, strong physician adoption, and ongoing technology investment for treating abnormal heart rhythms.
Dependence on Single-use Components to Drive Disposable Consumables Segment Expansion
By product, the market is categorized into disposable consumables, capital equipment, and reusable accessories. The disposable consumables segment is leading the market as every procedure requires single-use components like catheters and electrodes, creating a recurring revenue stream that scales with procedural volume.